Approval · Notice of Compliance 82 · 2003
KINERET: Notice of Compliance 82
Issued May 2, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 82
- Date
- May 2, 2003
- Company
- Amgen Canada IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in manufacturing process
- Therapeutic class
- Immunomodulatory agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KINERET | Not yet assigned | — |
Medicinal ingredients
- ANAKINRA 150 MG per ML